| abstract |
The present invention relates to compunds capable of binding to and/or modulating the activity of a Vpr or functional derivative thereof. The invention further relates to methods, products and uses of these compounds for modulation of Vpr-related activity, binding and detection of Vpr, as well as for therapy, diagnosis and/or prognostication of Vpr-related disease. The invention further relates to a method of screening in yeast for the identification of such compounds. |